CorMedix (CRMD) FCF Margin Growth (3y) (2018 - 2025)

CorMedix (CRMD) FCF Margin Growth (3y) (2018 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 15,064.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 723.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -1,409.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 CorMedix 546.82 Mn 391.62 Mn 107.31 Mn 2.12 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.12 Mn
Sep 30, 2025 8.91 Mn
Jun 30, 2025 2.58 Mn
Mar 31, 2025 8.84 Mn
Dec 31, 2024 1.15 Mn
Sep 30, 2024 1.64 Mn
Jun 30, 2024 3.61 Mn
Dec 31, 2022 -543,936.00
Sep 30, 2022 -8.24 Mn
Jun 30, 2022 -2.62 Mn
Mar 31, 2022 -8.39 Mn
Dec 31, 2021 1.56 Mn
Sep 30, 2021 -1.51 Mn
Jun 30, 2021 1.96 Mn
Mar 31, 2021 2.30 Mn
Dec 31, 2020 -278,779.00
Sep 30, 2020 328,640.00
Jun 30, 2020 108,145.00
Mar 31, 2020 631,857.00
Dec 31, 2019 535.75 Mn